Inflammatory elements have been thought of to contribute to keratoconus (KC) pathogenesis. This examine goals to find out the immune cells subsets and soluble inflammatory issue profile on the ocular floor of KC sufferers. 32 KC topics (51 eyes) throughout completely different grades of severity and 15 wholesome controls (23 eyes) have been included within the examine.
Keratometry and pachymetry measurements have been recorded. Ocular floor immune cells (collected by ocular floor wash) immunophenotyped utilizing stream cytometry embody leukocytes, neutrophils, macrophages, pure killer (NK) cells, pan-T cells, gamma delta T (γδT) cells and NKT cells.
Tear fluid collected utilizing Schirmer’s strip was used to measure 50 soluble elements by multiplex ELISA. Proportions of activated neutrophils, NK cells and γδT cells have been considerably elevated in KC sufferers. Considerably greater ranges of tear fluid IL-1β, IL-6, LIF, IL-17A, TNFα, IFNα/β/γ, EPO, TGFβ1, PDGF-BB, sVCAM, sL-selectin, granzyme-B, perforin, MMP2, sFasL and IgE, together with considerably decrease ranges of IL-1α and IL-9 have been noticed in KC sufferers.
Alterations noticed in few of the immuno-inflammatory parameters correlated with grades of illness, allergy, eye rubbing and keratometry or pachymetry measurements. The statement implies a definite immuno-inflammatory part in KC pathogenesis and its potential as a further therapeutic goal in KC administration.
Label-free identification of Erythropoietin isoforms by floor enhanced Raman spectroscopy
We current a delicate label-free floor enhanced Raman spectroscopy (SERS) technique for the discrimination between the recombinant and endogenous human Erythropoietin (EPO) isoforms. The proposed methodology contains a lectin-functionalised extractor chip for the extraction of the recombinant human EPO (rhuEPO) and the endogenous EPO (enEPO) from blood plasma.
The disulfide bond molecular construction of the purified isoforms was modified to chemisorb the biomolecules onto a SERS substrate in a unified orientation, thus maximizing the reproducibility and sensitivity of the SERS measurements.
The acquired SERS spectra of the EPO isoforms confirmed diagnostic Raman bands that allowed for the discrimination between rhuEPO and enEPO. The tactic was additionally used for the SERS quantification of rhuEPO and enEPO all the way down to 0.1 pM and 0.5 pM, respectively.
The SERS dedication of the protein isoforms was cross validated towards ELISA. The brand new SERS technique has sturdy potential for the speedy screening of rhuEPO doping in athletes and for the therapeutic drug monitoring of rhuEPO therapy in most cancers sufferers.
Impact of erythropoietin on angiogenic potential of dental pulp cells
Erythropoietin (EPO) is a 34-kDa glycoprotein that possesses the potential for angiogenesis, in addition to anti-inflammatory and anti-apoptotic properties. The current examine aimed to look at the impact of EPO on the angiogenesis of dental pulp cells (DPCs) and to discover the underlying mechanisms of those results.
It was demonstrated that EPO not solely promoted DPCs proliferation but additionally induced angiogenesis of DPCs in a paracrine style. EPO enhanced the angiogenic capability by stimulating DPCs to secrete a collection of angiogenic cytokines.
ELISA confirmed that top concentrations of EPO elevated the manufacturing of MMP-Three and angiopoietin-1 however decreased the secretion of IL-6. Moreover, EPO activated the ERK1/2 and p38 signaling pathways in DPCs, whereas inhibition of those pathways diminished the angiogenesis capability of DPCs. The current examine instructed that EPO could have an vital position within the restore and regeneration of dental pulp.
Erythropoietin improves neurobehavior by lowering dopaminergic neuron loss in a 6‑hydroxydopamine‑induced rat mannequin.
The aim of this examine was to find out the effectiveness of the systemic administration of excessive dose erythropoietin (EPO) in a 6‑hydroxydopamine (6‑OHDA)‑ induced rat mannequin. Rats have been divided into 7 teams. Teams 1‑Four have been administered day by day EPO doses of 0; 2,500; 5,000 and 10,000 U/kg by way of intraperitoneal injection (i.p.) for five days.
The EPO focus in cerebrospinal fluid (CSF) was decided by enzyme‑linked immunosorbent assay (ELISA) and western blot evaluation. The dose of 10,000 U/kg was then chosen for subsequent experiments. In group 5, rats obtained saline by way of medial forebrain bundle (MFB). In group 6, rats obtained 6‑OHDA by way of MFB.
In group 7, an EPO focus of 10,000 U/kg was consistently administered i.p. for five days to rats prior to six‑OHDA injection by way of MFB. Behavioral evaluation was carried out for teams 5‑7 by rat rotation exams. The variety of tyrosine hydroxylase (TH)‑immunopositive cells within the substantia nigra (SN) was measured by immuno-cyto-chemistry.
The activation of c‑Jun N‑terminal kinase (JNK), extracellular sign‑regulated kinase (ERK), p38 mitogen‑activated protein kinases (MAPKs) and caspase‑Three signaling in rats have been analyzed utilizing western blotting. The outcomes confirmed that there was a major enhance in EPO ranges within the CSF in 10,000 U/kg group in contrast with the two,500 and 5,000 U/kg teams (P<0.01).
Considerably fewer rotational counts have been obtained in rats that have been pretreated with EPO in contrast with saline‑pretreated 6‑OHDA‑lesioned rats (P<0.001). The dopaminergic neurons within the 6‑OHDA‑lesioned SN have been additionally elevated within the EPO‑pretreated rats in comparison with management rats (P<0.01).
Western blot evaluation revealed that EPO inhibited the 6‑OHDA‑induced activation of JNK, ERK, p38 MAPK and caspase‑Three signaling within the rat mannequin. In conclusion, systemic administration of a excessive dose of EPO exerted neuroprotective results in reversing behavioral deficits related to Parkinson’s illness and prevented lack of the dopaminergic neurons by means of the MAPK pathway.
Low Serum Erythropoietin Ranges are Related to Deadly COVID-19 Instances at 4,150 meters above sea stage
Earlier research instructed that erythropoietin (EPO) could shield towards extreme COVID-19-induced accidents, finally stopping mortality. This speculation is predicated on the truth that, along with selling the rise in purple blood cells, EPO is an anti-inflammatory, anti-apoptotic and protecting consider a number of non-erythropoietic tissues.
Moreover, EPO promotes nitric oxide manufacturing within the hypoxic lung and stimulates air flow by interacting with the respiratory facilities of the brainstem. On condition that EPO within the blood is elevated at high-altitude, we evaluated the serum ranges of EPO in important sufferers with COVID-19 at “Hospital Agramont” within the metropolis of El Alto (4,150 masl) in Bolivia.
A complete of 16 sufferers, 15 males, one girl, with a imply age of 55.8 ± 8.49 years, admitted to the Intensive Care Unit have been studied. All sufferers have been everlasting residents of El Alto, with no journey historical past beneath 3,000 masl for at the least one 12 months.
Blood samples have been collected upon admission to the ICU. Serum EPO focus was assessed utilizing an ELISA equipment, and a typical approach decided hemoglobin focus. Solely half of the noticed sufferers survived the illness. Remarkably, deadly circumstances confirmed 2.5 occasions decrease serum EPO than survivors (2.78 ± 0.8643 mU/ml vs 7.06 ± 2.713 mU/ml; p = 0.0096), and 1.24 occasions decrease hemoglobin ranges (13.96 ± 2.56 g/dL vs 17.41 ± 1.61 g/dL; p = 0.0159).
EPO ELISA KIT|Human |
|||
| EF000266 | Lifescience Market | 96 Tests | EUR 826.8 |
Human EPO ELISA Kit |
|||
| ELA-E0028h | Lifescience Market | 96 Tests | EUR 988.8 |
Monkey EPO ELISA Kit |
|||
| EMKE0009 | Abclonal | 96Tests | EUR 625.2 |
Rabbit EPO ELISA Kit |
|||
| ERTE0009 | Abclonal | 96Tests | EUR 625.2 |
Bovine EPO ELISA Kit |
|||
| EBE0009 | Abclonal | 96Tests | EUR 625.2 |
Canine EPO ELISA Kit |
|||
| ECE0009 | Abclonal | 96Tests | EUR 625.2 |
Porcine EPO ELISA Kit |
|||
| EPE0009 | Abclonal | 96Tests | EUR 625.2 |
Chicken EPO ELISA Kit |
|||
| ECKE0009 | Abclonal | 96Tests | EUR 625.2 |
Anserini EPO ELISA Kit |
|||
| EAE0009 | Abclonal | 96Tests | EUR 625.2 |
Guinea Pig EPO ELISA Kit |
|||
| EGE0009 | Abclonal | 96Tests | EUR 625.2 |
Mouse EPO ELISA kit (4X96T) |
|||
| LF-EK50630 | Abfrontier | 4×96T | EUR 2690.4 |
Epo ELISA Kit (Rat) (OKBB01541) |
|||
| OKBB01541 | Aviva Systems Biology | 96 Wells | EUR 684 |
|
Description: Description of target: Erythropoietin, EPO, also known as hematopoietin or hemopoietin, is a glycoprotein hormone that controls erythropoiesis, or red blood cell production. It is a cytokine for erythrocyte (red blood cell) precursors in the bone marrow. This gene is mapped to 7q22. It is said that the EPO gene encodes a deduced 193-amino acid propolypeptide. This hormone can be found in kidney and liver. It is the hormone that regulates red blood cell production. And it plays an important role in the brain's response to neuronal injury. What’s more, EPO is also involved in the wound healing process.;Species reactivity: Rat;Application: ELISA;Assay info: ;Sensitivity: <10pg/ml |
|||
EPO ELISA Kit (Rat) (OKCA00971) |
|||
| OKCA00971 | Aviva Systems Biology | 96 Wells | EUR 999.6 |
|
Description: Description of target: Erythropoietin is the principal hormone involved in the regulation of erythrocyte differentiation and the maintenance of a physiological level of circulating erythrocyte mass.;Species reactivity: Rat;Application: ;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.039 ng/mL |
|||
EPO ELISA Kit (Dog) (OKCD05661) |
|||
| OKCD05661 | Aviva Systems Biology | 96 Wells | EUR 1201.2 |
|
Description: Description of target: Erythropoietin is the principal hormone involved in the regulation of erythrocyte differentiation and the maintenance of a physiological level of circulating erythrocyte mass.;Species reactivity: Dog;Application: ELISA;Assay info: ;Sensitivity: < 13.7pg/mL |
|||
EPO ELISA Kit (Pig) (OKCD05664) |
|||
| OKCD05664 | Aviva Systems Biology | 96 Wells | EUR 1248 |
|
Description: Description of target: Hormone involved in the regulation of erythrocyte proliferation and differentiation and the maintenance of a physiological level of circulating erythrocyte mass. Binds to EPOR leading to EPOR dimerization and JAK2 activation thereby activating specific downstream effectors, including STAT1 and STAT3.;Species reactivity: Pig;Application: ELISA;Assay info: ;Sensitivity: < 12.1pg/mL |
|||
EPO ELISA Kit (Rat) (OKCD05665) |
|||
| OKCD05665 | Aviva Systems Biology | 96 Wells | EUR 981.6 |
|
Description: Description of target: acts as a regulator of erythropoiesis; may facilitate oxygen delivery in response to hypoxia.;Species reactivity: Rat;Application: ELISA;Assay info: ;Sensitivity: < 35.22pg/mL |
|||
EPO ELISA Kit (Rat) (OKBB00617) |
|||
| OKBB00617 | Aviva Systems Biology | 96 Wells | EUR 606 |
|
Description: Description of target: Erythropoietin, EPO, also known as hematopoietin or hemopoietin, is a glycoprotein hormone that controls erythropoiesis, or red blood cell production. It is a cytokine for erythrocyte (red blood cell) precursors in the bone marrow. This gene is mapped to 7q22. It is said that the EPO gene encodes a deduced 193-amino acid propolypeptide. This hormone can be found in kidney and liver. It is the hormone that regulates red blood cell production. And it plays an important role in the brain's response to neuronal injury. What’s more, EPO is also involved in the wound healing process.;Species reactivity: Rat;Application: ELISA;Assay info: Assay Methodology: Quantitative Sandwich Immunoassay;Sensitivity: <= 10 pg/mL |
|||
EPO ELISA Kit (Rat) (OKAN04974) |
|||
| OKAN04974 | Aviva Systems Biology | 96 Wells | EUR 950.4 |
|
Description: Description of target: acts as a regulator of erythropoiesis; may facilitate oxygen delivery in response to hypoxia [RGD, Feb 2006];Species reactivity: Rat;Application: ELISA;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 35.22 pg/mL |
|||
EPO ELISA Kit (Horse) (OKCD01439) |
|||
| OKCD01439 | Aviva Systems Biology | 96 Wells | EUR 1090.8 |
|
Description: Description of target: Erythropoietin is the principal hormone involved in the regulation of erythrocyte differentiation and the maintenance of a physiological level of circulating erythrocyte mass.;Species reactivity: Horse;Application: ;Assay info: Assay Methodology: Quantitative Sandwich Immunoassay;Sensitivity: < 11.6 pg/mL |
|||
Epo ELISA Kit (Mouse) (OKEH04502) |
|||
| OKEH04502 | Aviva Systems Biology | 96 Wells | EUR 652.8 |
|
Description: Description of target: This gene encodes the glycoprotein hormone erythropoietin that regulates the production of red blood cells and biosynthesis of hemoglobin. The predominant expression of this gene shifts from the liver during fetal development to kidney in adults. A complete lack of the encoded protein causes embryonic lethal anemia in mice. The conditional inactivation of this gene in adult mice results in a chronic, normocytic and normochromic anemia. Transgenic mice expressing the human ortholog of this gene exhibit polycythemia. Alternative splicing results in multiple transcript variants encoding different isoforms.;Species reactivity: Mouse;Application: ;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 39.4 pg/mL |
|||
EPO ELISA Kit (Sheep) (OKCA01956) |
|||
| OKCA01956 | Aviva Systems Biology | 96 Wells | EUR 1116 |
|
Description: Description of target: Erythropoietin is the principal hormone involved in the regulation of erythrocyte differentiation and the maintenance of a physiological level of circulating erythrocyte mass. ;Species reactivity: Sheep;Application: ;Assay info: Assay Methodology: Quantitative Sanadwich ELISA;Sensitivity: 0.078 ng/mL |
|||
EPO ELISA Kit (Human) (OKCD05662) |
|||
| OKCD05662 | Aviva Systems Biology | 96 Wells | EUR 950.4 |
|
Description: Description of target: This gene is a member of the EPO/TPO family and encodes a secreted, glycosylated cytokine composed of four alpha helical bundles. The protein is found in the plasma and regulates red cell production by promoting erythroid differentiation and initiating hemoglobin synthesis. This protein also has neuroprotective activity against a variety of potential brain injuries and antiapoptotic functions in several tissue types.;Species reactivity: Human;Application: ELISA;Assay info: ;Sensitivity: < 11.5pg/mL |
|||
EPO ELISA Kit (Mouse) (OKCD05663) |
|||
| OKCD05663 | Aviva Systems Biology | 96 Wells | EUR 730.8 |
|
Description: Description of target: This gene encodes the glycoprotein hormone erythropoietin that regulates the production of red blood cells and biosynthesis of hemoglobin. The predominant expression of this gene shifts from the liver during fetal development to kidney in adults. A complete lack of the encoded protein causes embryonic lethal anemia in mice. The conditional inactivation of this gene in adult mice results in a chronic, normocytic and normochromic anemia. Transgenic mice expressing the human ortholog of this gene exhibit polycythemia. Alternative splicing results in multiple transcript variants encoding different isoforms.;Species reactivity: Mouse;Application: ELISA;Assay info: ;Sensitivity: < 2.68pg/mL |
|||
EPO ELISA Kit (Mouse) (OKAN06030) |
|||
| OKAN06030 | Aviva Systems Biology | 96 Wells | EUR 950.4 |
|
Description: Description of target: This gene encodes the glycoprotein hormone erythropoietin that regulates the production of red blood cells and biosynthesis of hemoglobin. The predominant expression of this gene shifts from the liver during fetal development to kidney in adults. A complete lack of the encoded protein causes embryonic lethal anemia in mice. The conditional inactivation of this gene in adult mice results in a chronic, normocytic and normochromic anemia. Transgenic mice expressing the human ortholog of this gene exhibit polycythemia. Alternative splicing results in multiple transcript variants encoding different isoforms.;Species reactivity: Mouse;Application: ELISA;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 2.68 pg/mL |
|||
EPO ELISA Kit (Horse) (OKAN06518) |
|||
| OKAN06518 | Aviva Systems Biology | 96 Wells | EUR 950.4 |
|
Description: Description of target: ;Species reactivity: Horse;Application: ELISA;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 11.6 pg/mL |
|||
EPO ELISA Kit (Mouse) (OKBB00140) |
|||
| OKBB00140 | Aviva Systems Biology | 96 Tests | EUR 699.6 |
|
Description: Description of target: Erythropoietin, EPO, also known as hematopoietin or hemopoietin, is a glycoprotein hormone that controls erythropoiesis, or red blood cell production. It is a cytokine for erythrocyte (red blood cell) precursors in the bone marrow. Its gene is mapped to 7q22. It is said that the EPO gene encodes a deduced 193-amino acid propolypeptide. This hormone can be found in kidney and liver. It is the hormone that regulates red blood cell production. And it plays an important role in the brain's response to neuronal injury. What’s more, EPO is also involved in the wound healing process.;Species reactivity: Mouse;Application: ELISA;Assay info: ;Sensitivity: < 15 pg/ml |
|||
EPO ELISA Kit (Human) (OKBB00694) |
|||
| OKBB00694 | Aviva Systems Biology | 96 Wells | EUR 652.8 |
|
Description: Description of target: Erythropoietin(EPO), also known as hematopoietin or hemopoietin, is a glycoprotein cytokine secreted by the kidney in response to cellular hypoxia; it stimulates red blood cell production (erythropoiesis) in the bone marrow. It is mapped to 7q22.1. This gene encodes a secreted, glycosylated cytokine composed of four alpha helical bundles. The encoded protein is mainly synthesized in the kidney, secreted into the blood plasma, and binds to the erythropoietin receptor to promote red blood cell production, or erythropoiesis, in the bone marrow. Expression of this gene is upregulated under hypoxic conditions, in turn leading to increased erythropoiesis and enhanced oxygen-carrying capacity of the blood. Expression of this gene has also been observed in brain and in the eye, and elevated expression levels have been observed in diabetic retinopathy and ocular hypertension. Recombinant forms of the encoded protein exhibit neuroprotective activity against a variety of potential brain injuries, as well as antiapoptotic functions in several tissue types, and have been used in the treatment of anemia and to enhance the efficacy of cancer therapies. ;Species reactivity: Human;Application: ELISA;Assay info: ;Sensitivity: <1mIU/ml |
|||
EPO ELISA Kit (Human) (OKAN04531) |
|||
| OKAN04531 | Aviva Systems Biology | 96 Wells | EUR 950.4 |
|
Description: Description of target: This gene encodes a secreted, glycosylated cytokine composed of four alpha helical bundles. The encoded protein is mainly synthesized in the kidney, secreted into the blood plasma, and binds to the erythropoietin receptor to promote red blood cell production, or erythropoiesis, in the bone marrow. Expression of this gene is upregulated under hypoxic conditions, in turn leading to increased erythropoiesis and enhanced oxygen-carrying capacity of the blood. Expression of this gene has also been observed in brain and in the eye, and elevated expression levels have been observed in diabetic retinopathy and ocular hypertension. Recombinant forms of the encoded protein exhibit neuroprotective activity against a variety of potential brain injuries, as well as antiapoptotic functions in several tissue types, and have been used in the treatment of anemia and to enhance the efficacy of cancer therapies.;Species reactivity: Human;Application: ELISA;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 11.5 pg/mL |
|||
EPO ELISA Kit (Bovine) (OKEH03801) |
|||
| OKEH03801 | Aviva Systems Biology | 96 Wells | EUR 934.8 |
|
Description: Description of target: Erythropoietin is the principal hormone involved in the regulation of erythrocyte differentiation and the maintenance of a physiological level of circulating erythrocyte mass.;Species reactivity: Bovine;Application: ;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 35 pg/mL |
|||
EPO ELISA Kit (Rabbit) (OKCA01811) |
|||
| OKCA01811 | Aviva Systems Biology | 96 Wells | EUR 1116 |
|
Description: Description of target: Erythropoietin is the principal hormone involved in the regulation of erythrocyte differentiation and the maintenance of a physiological level of circulating erythrocyte mass.;Species reactivity: Rabbit;Application: ;Assay info: Assay Methodology: Quantitative Sanadwich ELISA;Sensitivity: 0.98 mU/mL |
|||
EPO ELISA Kit (Monkey) (OKEI00612) |
|||
| OKEI00612 | Aviva Systems Biology | 96 Wells | EUR 889.2 |
|
Description: Description of target: Hormone involved in the regulation of erythrocyte proliferation and differentiation and the maintenance of a physiological level of circulating erythrocyte mass. Binds to EPOR leading to EPOR dimerization and JAK2 activation thereby activating specific downstream effectors, including STAT1 and STAT3.;Species reactivity: Monkey;Application: ;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 18.75 pg/mL |
|||
Whereas the variety of circumstances evaluated on this work is low, our findings strongly warrant additional investigation of EPO ranges in COVID-19 sufferers at excessive and low altitudes. Our outcomes additionally assist the speculation that exogenous EPO administration may assist critically ailing COVID-19 sufferers overcome the illness.